Table of Contents Table of Contents
Previous Page  114 128 Next Page
Information
Show Menu
Previous Page 114 128 Next Page
Page Background

Scott, L.J., Mohlke, K.L., Bonnycastle, L.L., Willer, C.J., Li, Y., Duren, W.L.,

Erdos, M.R., Stringham, H.M., Chines, P.S., Jackson, A.U., et al. (2007).

A genome-wide association study of type 2 diabetes in Finns detects multiple

susceptibility variants. Science

316

, 1341–1345.

Shang, L., Hua, H., Foo, K., Martinez, H., Watanabe, K., Zimmer, M., Kahler,

D.J., Freeby, M., Chung, W., LeDuc, C., et al. (2014).

b

-cell dysfunction due

to increased ER stress in a stem cell model of Wolfram syndrome. Diabetes

63

, 923–933.

Shimomura, K., Girard, C.A., Proks, P., Nazim, J., Lippiat, J.D., Cerutti, F.,

Lorini, R., Ellard, S., Hattersley, A.T., Barbetti, F., and Ashcroft, F.M. (2006).

Mutations at the same residue (R50) of Kir6.2 (KCNJ11) that cause neonatal

diabetes produce different functional effects. Diabetes

55

, 1705–1712.

Steinthorsdottir, V., Thorleifsson, G., Reynisdottir, I., Benediktsson, R.,

Jonsdottir, T., Walters, G.B., Styrkarsdottir, U., Gretarsdottir, S., Emilsson,

V., Ghosh, S., et al. (2007). A variant in CDKAL1 influences insulin response

and risk of type 2 diabetes. Nat. Genet.

39

, 770–775.

Unoki, H., Takahashi, A., Kawaguchi, T., Hara, K., Horikoshi, M., Andersen, G.,

Ng, D.P., Holmkvist, J., Borch-Johnsen, K., Jørgensen, T., et al. (2008). SNPs

in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian

and European populations. Nat. Genet.

40

, 1098–1102.

Wei, F.Y., Suzuki, T., Watanabe, S., Kimura, S., Kaitsuka, T., Fujimura, A.,

Matsui, H., Atta, M., Michiue, H., Fontecave, M., et al. (2011). Deficit of

tRNA(Lys) modification by Cdkal1 causes the development of type 2 diabetes

in mice. J. Clin. Invest.

121

, 3598–3608.

Yamagata, K., Senokuchi, T., Lu, M., Takemoto, M., Fazlul Karim, M., Go, C.,

Sato, Y., Hatta, M., Yoshizawa, T., Araki, E., et al. (2011). Voltage-gated K+

channel KCNQ1 regulates insulin secretion in MIN6

b

-cell line. Biochem.

Biophys. Res. Commun.

407

, 620–625.

Yasuda, K., Miyake, K., Horikawa, Y., Hara, K., Osawa, H., Furuta, H., Hirota,

Y., Mori, H., Jonsson, A., Sato, Y., et al. (2008). Variants in KCNQ1 are asso-

ciated with susceptibility to type 2 diabetes mellitus. Nat. Genet.

40

, 1092–

1097.

Zhang, S., Liu, J., MacGibbon, G., Dragunow, M., and Cooper, G.J. (2002).

Increased expression and activation of c-Jun contributes to human amylin-

induced apoptosis in pancreatic islet beta-cells. J. Mol. Biol.

324

, 271–285.

340

Cell Stem Cell

19

, 326–340, September 1, 2016